WNV M anticorps (AA 190-240)

N° du produit ABIN6990505

Cet anticorps Lapin Polyclonal détecte spécifiquement WNV M dans ELISA. Il présente une réactivité envers West Nile Virus (WNV).

Aperçu rapide pour WNV M anticorps (AA 190-240) (ABIN6990505)

Antigène: WNV M (West Nile Virus Matrix (WNV M))

Reactivité: West Nile Virus (WNV)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp WNV M est non-conjugé

Application: ELISA

Détail du produit anti-WNV M anticorps

Épitope: AA 190-240

Purification: West Nile Virus Matrix Antibody is affinity chromatography purified via peptide column.

Immunogène: West Nile virus matrix antibody was raised against a synthetic peptide corresponding to 15 amino acids near the middle of the west nile virus matrix precursor protein. The immunogen is located within amino acids 190 - 240 of West Nile Virus Matrix.

Isotype: IgG

Information d'application

Indications d'application: West Nile virus matrix antibody can be used for the detection of the West Nile virus matrix precursor protein in ELISA. It will detect 10 ng of free peptide at 1 μ,g/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: West Nile Virus Matrix Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: West Nile Virus Matrix antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur WNV M

Antigène: WNV M (West Nile Virus Matrix (WNV M))

Autre désignation: West Nile Virus Matrix

Classe de substances: Viral Protein

Sujet: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus, this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin.

ID gène: 912267

NCBI Accession: NP_776012

UniProt: P06935